Dual RAAS inhibition and cardiorenal disease: is enough really enough?

Intern Emerg Med. 2020 Apr;15(3):361-363. doi: 10.1007/s11739-020-02313-3. Epub 2020 Mar 21.

Authors

Claudio Borghi¹, Maddalena Veronesi², Stefano Bacchelli², Daniela Degli Esposti²

Affiliations

¹ Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy. claudio.borghi@unibo.it.
² Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.

PMID: 32200519
DOI: 10.1007/s11739-020-02313-3

No abstract available

Publication types

Comment

MeSH terms

Angiotensin-Converting Enzyme Inhibitors
Humans
Hypertension, Renal*
Kidney
Nephritis*
Renin-Angiotensin System

Substances

Angiotensin-Converting Enzyme Inhibitors